L308-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

L308-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide
L308-0530 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L308-0530
N-(2H-1,3-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L308-0530

Molecular Formula

C22H22N4O6S (C22 H22 N4 O6 S)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-3-{3-[4-(pyrrolidine-1-sulfonyl)phenyl]-124-oxadiazol-5-yl}propanamide

SMILES

O=C(CCc1nc(-c(cc2)ccc2S(N2CCCC2)(=O)=O)no1)Nc(cc1)cc2c1OCO2

InChI

InChI=1S/C22H22N4O6S/c27-20(23-16-5-8-18-19(13-16)31-14-30-18)9-10-21-24-22(25-32-21)15-3-6-17(7-4-15)33(28,29)26-11-1-2-12-26/h3-8,13H,1-2,9-12,14H2,(H,23,27)

InChI Key

ABGQGCMYMOYAAH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15123412

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.51

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.303

Distribution Coefficient, logD

3.303

Water Solubility, LogSw

-3.75

Polar Surface Area

103.652

Acid Dissociation Constant (pKa)

11.21

Base Dissociation Constant (pKb)

2.70

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

L308-0530 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with L308-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L308-0530?
Check Price and Availability of L308-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L308-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L308-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L308-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L308-0530 available by request